Print version of this report

TGA Action ID	RC-2026-RN-00900-1
Type of Product	Medicine
Product Name/Description	JSHealth Vitamins Immune+ 60 tablets Batch Numbers: All batches within expiry Expiry Dates: 30/04/2028, 31/10/2028 ARTG 333207 (cancelled)
ARTG Number
Action Type	Recall
Action Level	Consumer
Hazard Classification	Class I
Reason for the Action	Since 2019, listed medicines containing Andrographis paniculata (Andrographis) for supply in Australia have been required to carry a label warning about the risk of allergic reactions including severe reactions such as anaphylaxis. However, despite these warnings, the TGA has continued to receive a sustained high number of reports of anaphylaxis associated with Andrographis-containing listed medicines, which are considered low-risk medicines. Andrographis has now been removed from the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026. This means the ingredient is no longer available for use in new listed (low risk) medicines for supply in Australia.
Instructions for Customers/Users	Distributors/retailers are to: · Inspect their stock immediately and quarantine all stock of Immune+ on hand to prevent further use or distribution. · Following receipt of the completed Customer Response Form, the sponsor will contact customers to arrange the return/disposal of the affected stock and credit for the affected stock. · Retailers are recommended to place the ‘Public Notice’ in their storefront to alert consumers about the recall. Consumers: · Consumers are advised that if they have the above product, to not use it. · Consumers can return the product to the place of purchase, or contact JSHealth Customer Care to arrange the return of product for a refund. · If someone is suspected of having anaphylaxis, call for emergency medical help immediately by dialling ‘000’.
Action Commencement Date	6/11/2026
Responsible Entity	JSHealth Vitamins Pty Ltd
Contact Information	0405 802 877, jshealthvitaminsrecall@jshealthvitamins.com - JSHealth Customer Care